Literature DB >> 29018044

Rnf43.

Stefano Serra1, Runjan Chetty1.   

Abstract

RNF43 (E3 ubiquitin-protein ligase RNF43 or RING-type E3 ubiquitin transferase RNF43) functions as a tumor suppressor, by exerting a predominant negative feedback mechanism in the Wnt/β-catenin signaling pathway. RNF43 inhibits Wnt/beta-catenin signaling by ubiquitinating Frizzled receptor and targeting it to the lysosomal pathway for degradation. Loss of function of RNF43 results in decrease/lack of degradation of Frizzled with enhancement of Wnt/β-catenin signaling pathway. Mutations of RNF43 have been reported in different cancers. We describe the structure of RNF43, its function and most frequent mutations in different cancers. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  cancer; colorectal cancer; gi neoplasms pancreatic

Mesh:

Substances:

Year:  2017        PMID: 29018044     DOI: 10.1136/jclinpath-2017-204763

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  6 in total

1.  Detection of Human papillomavirus and the role of p16INK4a in colorectal carcinomas.

Authors:  Larisse Silva Dalla Libera; Thalita de Siqueira; Igor Lopes Santos; Jéssica Enocencio Porto Ramos; Amanda Xavier Milhomen; Rita de Cassia Gonçalves de Alencar; Silvia Helena Rabelo Santos; Megmar Aparecida Dos Santos Carneiro; Rosane Ribeiro Figueiredo Alves; Vera Aparecida Saddi
Journal:  PLoS One       Date:  2020-06-25       Impact factor: 3.240

Review 2.  Wnt/β-Catenin Signaling: The Culprit in Pancreatic Carcinogenesis and Therapeutic Resistance.

Authors:  Monish Ram Makena; Himavanth Gatla; Dattesh Verlekar; Sahithi Sukhavasi; Manoj K Pandey; Kartick C Pramanik
Journal:  Int J Mol Sci       Date:  2019-08-30       Impact factor: 5.923

3.  Exome sequencing revealed comparable frequencies of RNF43 and BRAF mutations in Middle Eastern colorectal cancer.

Authors:  Abdul Khalid Siraj; Rong Bu; Tariq Masoodi; Sandeep Kumar Parvathareddy; Kaleem Iqbal; Wael Al-Haqawi; Hassan Al-Dossari; Saud Azam; Zeeshan Qadri; Padmanaban Annaiyappanaidu; Fouad Al-Dayel; Khawla Sami Al-Kuraya
Journal:  Sci Rep       Date:  2022-07-30       Impact factor: 4.996

4.  RNF43 mutation is associated with aggressive tumor biology along with BRAF V600E mutation in right-sided colorectal cancer.

Authors:  Akio Matsumoto; Yoshifumi Shimada; Mae Nakano; Hidehito Oyanagi; Yosuke Tajima; Masato Nakano; Hitoshi Kameyama; Yuki Hirose; Hiroshi Ichikawa; Masayuki Nagahashi; Hitoshi Nogami; Satoshi Maruyama; Yasumasa Takii; Yiwei Ling; Shujiro Okuda; Toshifumi Wakai
Journal:  Oncol Rep       Date:  2020-03-23       Impact factor: 3.906

Review 5.  Actionable Potentials of Less Frequently Mutated Genes in Colorectal Cancer and Their Roles in Precision Medicine.

Authors:  Ryia Illani Mohd Yunos; Nurul Syakima Ab Mutalib; Francis Yew Fu Tieng; Nadiah Abu; Rahman Jamal
Journal:  Biomolecules       Date:  2020-03-20

Review 6.  Emerging protein degradation strategies: expanding the scope to extracellular and membrane proteins.

Authors:  Jiayi Lin; Jinmei Jin; Yiwen Shen; Lijun Zhang; Gang Gong; Huiting Bian; Hongzhuan Chen; Dale G Nagle; Ye Wu; Weidong Zhang; Xin Luan
Journal:  Theranostics       Date:  2021-07-13       Impact factor: 11.556

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.